RxDoctor Payments Data

Richard Ray

Psychiatric/Mental Health · Gulfport, MSNPI 1306147947

Payments from drug & device makers

$1,972in general payments, 2019–2025

Across 110 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$340
  • Alkermes, Inc.$321
  • AbbVie$312
  • Lundbeck LLC$217
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$204
  • Vanda Pharmaceuticals Inc.$181
  • plus $396 from 8 others

What the payments were for

  • Food & beverage$1,94499%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,972 in reported general payments places this provider in the 70th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Medicare billing

Part B allowed, 2024
$48,423
Medicare patients
167
Services billed
593

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine18$90,714
Chlorpromazine Hcl107$45,786
Divalproex Sodium149$6,401
Naltrexone Hcl80$5,331
Haloperidol65$3,144
Quetiapine Fumarate177$2,926
Olanzapine123$2,642
Benztropine Mesylate170$2,543
Paliperidone ErPaliperidone15$2,047
Risperidone158$1,911
Divalproex Sodium ErDivalproex Sodium24$1,714
Aripiprazole87$1,410
Quetiapine Fumarate ErQuetiapine Fumarate27$1,367
Lorazepam129$986
Valproic AcidValproic Acid (As Sodium Salt)12$803

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$112$90,71418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →